Board Meeting5 May 2026, 05:11 pm
Emmessar Biotech Board Meeting on 12/05/2026 to Approve Results
AI Summary
Emmessar Biotech & Nutrition Ltd has scheduled a Board of Directors meeting on May 12, 2026, to consider and approve the Audited Financial Results of the Company for the year ended March 31, 2026. The trading window for dealing in the company's equity shares will remain closed until May 14, 2026.
Key Highlights
- Board meeting scheduled for May 12, 2026, to approve audited financial results.
- Financial results are for the year ended March 31, 2026.
- Trading window closed until May 14, 2026, as per insider trading regulations.
Price Impact
More from EMMESSA